Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Dipna Pharmachem Rights Issue 2024 and Nagreeka Exports Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Dipna Pharmachem Rights Issue 2024 and Nagreeka Exports Rights Issue 2024. Dipna Pharmachem Rights Issue 2024 is listed on BSE while Nagreeka Exports Rights Issue 2024 is listed on BSE, NSE.
| Dipna Pharmachem Ltd. | Nagreeka Exports Ltd. | |
|---|---|---|
| Logo |  |
 |
| Listing At | BSE | BSE, NSE |
| Terms of Payment | Full amount of Rs. 10/- per Equity share is payable on application by Eligible Equity shareholders. |
The full amount of the Issue Price being Rs.20/- will be payable on application. |
| Entitlement | 13 Rights Equity Share(s) for every 12 fully paid-up Equity Shares held on Record Date | 3 Rights Equity Share(s) for every 2 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  |
Application Form |
| Letter of Offer | Letter of Offer |
Letter of Offer |
| Registrar | Bigshare Services Pvt Ltd | Maheshwari Datamatics Pvt. Ltd |
| Lead Managers | Prime Securities Limited |
The issue size of Dipna Pharmachem Rights Issue 2024 rights issue is ₹12.97 Crores, whereas Nagreeka Exports Rights Issue 2024 rights issue size is ₹37.50 Crores.
| Dipna Pharmachem Ltd. | Nagreeka Exports Ltd. | |
|---|---|---|
| Issue Size | 1,29,67,500 shares | 1,87,49,550 shares |
| Issue Size (Amount) | ₹12.97 Crores | ₹37.50 Crores |
| Issue Price | ₹10 per share | ₹20 per share |
| Face Value | ₹10 per share | ₹5 per share |
Find all the important dates related to the rights issue. The record date of Dipna Pharmachem Rights Issue 2024 is Feb 12, 2024 while record date of Nagreeka Exports Rights Issue 2024 is Jan 30, 2024.
| Dipna Pharmachem Ltd. | Nagreeka Exports Ltd. | |
|---|---|---|
| Record Date | Feb 12, 2024 | Jan 30, 2024 |
| Credit of Rights Entitlements | Feb 19, 2024 | |
| Bid/Offer Opens On | Feb 26, 2024 | Feb 12, 2024 |
| Renunciation of Rights Entitlements | Mar 04, 2024 | Feb 19, 2024 |
| Bid/Offer Closes On | Mar 20, 2024 | Feb 23, 2024 |
| Deemed Date of Allotment | Mar 14, 2024 | Mar 05, 2024 |
| Credit Date | Mar 15, 2024 | Mar 14, 2024 |
| Listing Date | Mar 18, 2024 | Mar 19, 2024 |
Comparison of Dipna Pharmachem Rights Issue 2024 and Nagreeka Exports Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Dipna Pharmachem Ltd. | Nagreeka Exports Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Dipna Pharmachem Ltd. Financial Information (Restated)Dipna Pharmachem Ltd.'s revenue increased by 37.34% and profit after tax (PAT) dropped by -21.85% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Nagreeka Exports Ltd. Financial Information (Restated)Nagreeka Exports Ltd.'s revenue decreased by -29.29% and profit after tax (PAT) dropped by -51.01% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
